Cost-effectiveness Of Cetuximab In Metastatic Colorectal Cancer

Friday, August 7, 2009 - 16:28 in Health & Medicine

From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a new study.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net